Cite
HARVARD Citation
Giunta, A. et al. (2021). A single-centre, observational, retrospective, real-life study evaluating adalimumab biosimilar ABP 501 in the treatment of plaque-type psoriasis and psoriatic arthritis in originator-naïve patients and in patients undergoing non-medical switch from originator. Current medical research and opinion. pp. 1099-1102. [Online].